Eli Lilly wins FDA approval for weight loss pill, boosts rival Novo – Pharmaceutical Technology

Eli Lilly wins FDA approval for weight loss pill, boosts rival Novo - Pharmaceutical Technology

Lilly will hope that Foundayo continues to dominate and grow over Novo Nordisk in the obesity drug market. Credit: Michael Vi / Shutterstock.com. The US Food and Drug Administration (FDA) has approved Eli Lilly’s orforglipron pill for weight loss, ending Novo Nordisk’s first mover profits in the US after just three months. Oral glucagon-like peptide-1 … Read more

FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market

Eli Lilly CEO: Our pill supply could 'reach the planet'

The US Food and Drug Administration has approved it Eli LillyPills GLP-1 ‘s, said the company, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight loss medications. Lilly said the once-daily pill, Foundayo, will begin shipping from LillyDirect’s direct-to-consumer platform on Monday and will be available in … Read more